Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Managed care: What are the potential implications for obstetric and gynaecological practice in Australia?

Loading...
Thumbnail Image

Date

Authors

Robson, Stephen
Looi, Jeffrey

Journal Title

Journal ISSN

Volume Title

Publisher

Blackwell Publishing Ltd

Abstract

America's health care system is neither healthy, caring, nor a system. – Walter Cronkite The Australia Competition and Consumer Commission (ACCC) recently released a ‘draft determination’ regarding a proposal from a commercial group known as Honeysuckle Health (HH) – a ‘buying group’ formed by a merger of the Australian for-profit health insurer NIB and US-based Cigna corporation to purchase healthcare provider services on behalf of private health insurers (PHIs) – granting provisional approval for the group to begin operations in Australia.1 The application was strongly opposed by a broad range of Australian healthcare groups, from medico-political organisations such as the Australian Medical Association (AMA) and the Australian Doctors’ Federation to specialist colleges such as the Royal Australasian College of Surgeons (RACS).2 The central concerns are that ‘the application will introduce US-style managed care into Australia [representing] a direct threat to Medicare and Australian private hospitals’.3 Concerns about buying-group mediated ‘managed care’ have also come from diverse medical specialties such as anaesthetists4 and psychiatrists.5 In their submission to the ACCC, RACS2 warned that under this model, if a surgeon operates in a private hospital and the hospital agrees to be contracted to a total no gap experience but a surgeon does not, this could then lead to damage to the surgeon’s practice by being banned from operating on their patients at that hospital, reducing patient’s choice and autonomy. It may well impair a clinical decision to order an additional scan, or pathology test or engage the care of another specialist for an unexpected complication as it would fall outside the value proposition of Honeysuckle and the funds. Bradley and colleagues4 have written that the HH-NIB proposal ‘should be of concern to all Australians as it is a deliberate step towards US-style managed care. What is at stake is the future of Australian health care’. In the preliminary approval of the HH-NIB buying group, the ACCC focused on narrow economic and regulatory considerations, thus failing to consider the broader consequences for Australian healthcare.6 HH-NIB provides benefits to the insurers through the asymmetric concentration of bargaining power by PHIs to negotiate with healthcare providers, including medical specialists and private hospitals.6 HH-NIB have additionally sought to bargain on behalf of up to 60% of PHIs, greatly reducing competition among PHIs, against the public interest of patients.6 Since the COVID-19 pandemic has already placed enormous stress on the Australian health system, any further changes may have drastic consequences. As Blecher and colleagues7 have put it, the pandemic already has put in sharp focus: ongoing concerns about the viability of private health insurance, the roles of profiteering by multinational health insurance providers, and the reliance of payee contributions and government subsidies to prop up a model which is ultimately answerable to its shareholders are ultimately complex system questions. The temporary successful merging of public and private systems that occurred during the pandemic opens the possibility of more symbiotic cooperation between the systems in the future. A number of new models for private hospital obstetric care recently have been promoted and, according to the AMA, could represent a ‘gateway to managed care’.8 However, many obstetricians and gynaecologists do not understand what ‘managed care’ is and what its implications are. For this reason, we present an evidence-based primer on managed care and its impact on women’s healthcare.

Description

Keywords

Citation

Source

Australian and New Zealand Journal of Obstetrics and Gynecology

Book Title

Entity type

Access Statement

License Rights

Restricted until

2099-12-31